Feed JSPR
JS

Jasper Therapeutics, Inc. JSPR NASDAQ · Healthcare · United States

$11.77 -13.96% -$1.91

Market cap
$13.1M
Enterprise value
$6.01M
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/FCF
-
EV/EBITDA
-
ROIC
-1,305.0%
Gross margin
-
Net margin
-
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-
Beta
3.31
Free float
89.6%

About the company

Jasper Therapeutics, Inc. (JSPR) is a biotechnology company based in the USA that specializes in researching and developing novel therapeutic approaches in the field of hematopoiesis and cell therapy. The company focuses on treating hematological disorders and other diseases related to blood formation and the immune system. Their research centers on the use of stem cells and cell therapy to regenerate hematopoietic tissues and treat various diseases. Jasper Therapeutics aims to bring innovative and effective treatment methods that could revolutionize medical practices and improve the quality of life for patients. With the growing interest in the biotechnology industry, shares of Jasper Therapeutics, Inc. could present an intriguing investment opportunity for those who believe in the prospects of biotechnology and new therapeutic approaches.

Sector

Healthcare

Industry

Biotechnology

CEO

Jeetinder Singh Mahal

Employees

22

Headquarters

Redwood City

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

  • What to watch: It missed profit estimates 5 times in the last 8 quarters.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

  • What speaks for it: It holds more cash than debt: $135.3M against $69.0K.
  • What to watch: It passes only 2 of the 9 points of the Piotroski financial health test.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy